← Back to Search

Head and neck cancer patients for Cancer (EXERT-C Trial)

N/A
Recruiting
Research Sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

EXERT-C Trial Summary

This protocol seeks to analyze patient outcomes of the standard of care, monitored group exercise regimen of high-load resistance training and functional exercises with compound movements under close supervision on individuals who have been treated for cancer.

EXERT-C Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Determine changes in fat mass in pounds from before to after the nutrition and exercise regimen via bioimpedance analysis
Determine changes in fat mass in pounds from before to after the nutrition and exercise regimen via ultrasound
Determine changes in muscle mass in pounds from before to after the nutrition and exercise regimen
Secondary outcome measures
Determine changes in EQ-5D responses 1-5 and overall score from before to after the nutrition and exercise regimen
Determine changes in Y-balance score for each leg
Determine changes in overall score of functional movement screen (FMS) from before to after the nutrition and exercise regimen
+1 more

EXERT-C Trial Design

5Treatment groups
Experimental Treatment
Group I: Pancreatic cancer patientsExperimental Treatment1 Intervention
All patients undergoing treatment for pancreatic cancer on an exercise regime
Group II: Metastatic breast cancer patientsExperimental Treatment1 Intervention
All patients undergoing treatment for metastatic breast cancer on an exercise regime
Group III: Head and neck cancer patientsExperimental Treatment1 Intervention
All patients undergoing treatment for head and neck cancer on an exercise regime
Group IV: General cancer patientsExperimental Treatment1 Intervention
All patients undergoing treatment for cancer on an exercise regimen
Group V: Colorectal cancer patientsExperimental Treatment1 Intervention
All patients undergoing treatment for colorectal cancer on an exercise regime

Find a Location

Who is running the clinical trial?

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)Lead Sponsor
47 Previous Clinical Trials
12,979 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Cancer
2023. "EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06083324.
All > Paid Studies Pittsburgh
~46 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top